NVAX
Price
$5.59
Change
-$0.39 (-6.52%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
961.85M
34 days until earnings call
WXIBF
Price
$3.70
Change
+$0.15 (+4.23%)
Updated
Mar 19 closing price
Capitalization
13.82B
Ad is loading...

NVAX vs WXIBF

Header iconNVAX vs WXIBF Comparison
Open Charts NVAX vs WXIBFBanner chart's image
Novavax
Price$5.59
Change-$0.39 (-6.52%)
Volume$98.84K
Capitalization961.85M
Wuxi Biologics Cayman
Price$3.70
Change+$0.15 (+4.23%)
Volume$850
Capitalization13.82B
NVAX vs WXIBF Comparison Chart
Loading...
NVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVAX vs. WXIBF commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVAX is a Hold and WXIBF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (NVAX: $5.98 vs. WXIBF: $3.70)
Brand notoriety: NVAX: Notable vs. WXIBF: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NVAX: 251% vs. WXIBF: 82%
Market capitalization -- NVAX: $899.92M vs. WXIBF: $13.08B
NVAX [@Biotechnology] is valued at $899.92M. WXIBF’s [@Biotechnology] market capitalization is $13.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVAX’s FA Score shows that 0 FA rating(s) are green whileWXIBF’s FA Score has 1 green FA rating(s).

  • NVAX’s FA Score: 0 green, 5 red.
  • WXIBF’s FA Score: 1 green, 4 red.
According to our system of comparison, WXIBF is a better buy in the long-term than NVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVAX’s TA Score shows that 4 TA indicator(s) are bullish.

  • NVAX’s TA Score: 4 bullish, 4 bearish.

Price Growth

NVAX (@Biotechnology) experienced а -19.08% price change this week, while WXIBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

NVAX is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WXIBF($13.8B) has a higher market cap than NVAX($962M). WXIBF YTD gains are higher at: 70.507 vs. NVAX (-25.622). WXIBF has higher annual earnings (EBITDA): 5.5B vs. NVAX (-108.04M). WXIBF has higher revenues than NVAX: WXIBF (17B) vs NVAX (682M).
NVAXWXIBFNVAX / WXIBF
Capitalization962M13.8B7%
EBITDA-108.04M5.5B-2%
Gain YTD-25.62270.507-36%
P/E RatioN/A34.43-
Revenue682M17B4%
Total Cash923MN/A-
Total Debt230MN/A-
FUNDAMENTALS RATINGS
NVAX vs WXIBF: Fundamental Ratings
NVAX
WXIBF
OUTLOOK RATING
1..100
5146
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10043
PRICE GROWTH RATING
1..100
6535
P/E GROWTH RATING
1..100
1006
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WXIBF's Valuation (75) in the null industry is in the same range as NVAX (87) in the Biotechnology industry. This means that WXIBF’s stock grew similarly to NVAX’s over the last 12 months.

WXIBF's Profit vs Risk Rating (100) in the null industry is in the same range as NVAX (100) in the Biotechnology industry. This means that WXIBF’s stock grew similarly to NVAX’s over the last 12 months.

WXIBF's SMR Rating (43) in the null industry is somewhat better than the same rating for NVAX (100) in the Biotechnology industry. This means that WXIBF’s stock grew somewhat faster than NVAX’s over the last 12 months.

WXIBF's Price Growth Rating (35) in the null industry is in the same range as NVAX (65) in the Biotechnology industry. This means that WXIBF’s stock grew similarly to NVAX’s over the last 12 months.

WXIBF's P/E Growth Rating (6) in the null industry is significantly better than the same rating for NVAX (100) in the Biotechnology industry. This means that WXIBF’s stock grew significantly faster than NVAX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVAX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 22 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
NVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APDQX15.430.13
+0.85%
Artisan Mid Cap Value Advisor
RICAX55.660.29
+0.52%
American Funds Invmt Co of Amer R1
ISJBX19.14N/A
N/A
Voya US Stock Index Port S
BISCX18.37N/A
N/A
UBS US Small Cap Growth P
WOOQX17.48N/A
N/A
JPMorgan SMID Cap Equity R4

NVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVAX has been loosely correlated with THRD. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NVAX jumps, then THRD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVAX
1D Price
Change %
NVAX100%
-0.33%
THRD - NVAX
42%
Loosely correlated
+5.65%
ITOS - NVAX
42%
Loosely correlated
+2.49%
ADMA - NVAX
34%
Loosely correlated
+4.17%
ARCT - NVAX
33%
Poorly correlated
+8.17%
EDIT - NVAX
33%
Poorly correlated
+4.42%
More

WXIBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, WXIBF has been loosely correlated with WXXWY. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if WXIBF jumps, then WXXWY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WXIBF
1D Price
Change %
WXIBF100%
N/A
WXXWY - WXIBF
46%
Loosely correlated
-1.31%
JAGX - WXIBF
22%
Poorly correlated
-1.89%
NVAX - WXIBF
21%
Poorly correlated
-0.33%
ELVAF - WXIBF
21%
Poorly correlated
N/A
EVAX - WXIBF
20%
Poorly correlated
+1.81%
More